The continuum between healthy ageing and idiopathic Parkinson Disease within a propagation perspective of inflammation and damage: the search for new diagnostic, prognostic and therapeutic targets. Phase 2
- Conditions
- G20.9
- Registration Number
- DRKS00011260
- Lead Sponsor
- IRCCS Istituto delle Scienze Neurologiche di Bologna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 345
Inclusion Criteria
1.Siblings of patients with a diagnosis of sporadic idiopathic Parkinson’s Disease, according to the International Diagnostic Criteria [UK Brain Bank Criteria];
2.signed informed consent
Exclusion Criteria
1.Diagnosis of sporadic idiopathic Parkinson’s Disease according to the UK Brain Bank Criteria;
2.patients affected by clinically relevant diseases of the Central Nervous System (i.e. Alzheimer’s disease, Vascular Encephalopathies, Multiple Sclerosis, etc.).
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To validate biomarkers for early diagnosis of Parkinson Disease
- Secondary Outcome Measures
Name Time Method